rekr_8ka.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

(Amendment No. 2)

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 18, 2021

 

REKOR SYSTEMS, INC.

 (Exact name of registrant as specified in its charter)

  

Delaware

 

001-38338

 

81-5266334

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

7172 Columbia Gateway Drive, Suite 400, Columbia, MD 21046

(Address of Principal Executive Offices)

 

Registrant's Telephone Number, Including Area Code: (410) 762-0800

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.0001 par value per share

REKR

 The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

 

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

  

Explanatory Note

 

On August 19, 2021, Rekor Systems, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original 8-K”), as amended by Amendment No. 1 to the Original 8-K (“Amendment No. 1”), disclosing, among other things, that on August 18, 2021, Rekor completed the transaction contemplated by the share purchase agreement (the “Purchase Agreement”) by and among the Company, Waycare Technologies Ltd. (“Waycare”), the sellers of Waycare named in the Purchase Agreement (the “Sellers”), and Shareholder Representative Services LLC, solely in its capacity as the representative of the Sellers, pursuant to which the Company acquired 100% of the issued and outstanding capital stock of Waycare from the Sellers.

 

This second amendment to the Original 8-K (“Amendment No. 2”) is being filed for the purpose of satisfying the Company’s undertaking to file the financial statements and pro forma financial information required by Item 9.01 of Form 8-K, and this Amendment No. 2 should be read in conjunction with the Original 8-K, as amended by Amendment No. 1. Except as set forth herein, no modifications have been made to information contained in the Original 8-K and Amendment No. 1, and the Company has not updated any information contained therein to reflect events that have occurred since the date of the Original 8-K.

 

Item 9.01. Financial Statements and Exhibits.

 

(a) Financial Statements of Business Acquired.

 

The audited consolidated financial statements of Waycare for the year ended December 31, 2020 and the unaudited consolidated financial statements for the six months ended June 30, 2021 and the related notes are attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

(b) Pro Forma Financial Information.

 

Unaudited pro forma condensed combined financial statements, which include a pro forma condensed combined balance sheet as of June 30, 2021 and pro forma condensed combined statements of operations for the year ended December 31, 2020 and the six months ended June 30, 2021 and the notes related thereto, are filed as Exhibit 99.2 to this report and incorporated herein by reference.

 

(d) Exhibits

 

Exhibit
No.

 

Description

23.1

 

Consent of Independent Auditors of Waycare Technologies Ltd.

99.1

 

Audited consolidated financial statements of Waycare Technologies Ltd. For the year ended December 31, 2020 and the related notes to such financial statements, and unaudited consolidated financial statements of Waycare Technologies Ltd. For the six months ended June 30, 2021 and the related notes to such financial statements.

99.2

 

Unaudited pro forma condensed combined financial statements, which include a pro forma condensed combined balance sheet as of June 30, 2021 and pro forma condensed combined statements of operations for the year ended December 31, 2020 and for the six months ended June 30, 2021 and the notes related thereto.

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

2

 

      

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

REKOR SYSTEMS, INC.

 

 

 

 

 

Date: September 14, 2021

 

/s/ Robert A. Berman

 

 

 

Name: Robert A. Berman

Title: President and Chief Executive Officer

 

 

 

3

 

 

EXHIBIT 23.1

 

Consent of Independent Auditors

 

We consent to the incorporation by reference in Registration Statements on Form S-3 (No. 333-259447) and on Form S-8 (Nos. 333-220864 and 333-259041) of Rekor Systems, Inc. of our report dated September 14, 2021, relating to the financial statements of Waycare Technologies Ltd. as of December 31, 2020 and for the year ended December 31, 2020, appearing in the Current Report on Form 8-K/A of Rekor Systems, Inc.

 

/s/ KOST FORER GABBAY & KASIERER

 

A Member of Ernst & Young Global

 

Tel-Aviv, Israel

September 14, 2021

 

 

EXHIBIT 99.1

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

CONSOLIDATED FINANCIAL STATEMENTS

 

AS OF DECEMBER 31, 2020

 

U.S. DOLLARS IN THOUSANDS

 

INDEX

 

 

Page

 

 

Report of Independent Auditors

2

 

 

Consolidated Balance Sheet

3

 

 

Consolidated Statement of Comprehensive loss

4

 

 

Consolidated Statements of Convertible Preferred Shares and Shareholders' Deficiency

5

 

 

Consolidated Statement of Cash Flow

6

 

 

Notes to Consolidated Financial Statements

7 - 19

 

 
- 1 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

   

 

Kost Forer Gabbay & Kasierer

144 Menachem Begin Road, Building A,

Tel-Aviv 6492102, Israel

 

Tel: +972-3-6232525

Fax: +972-3-5622555

ey.com

 

 

REPORT OF INDEPENDENT AUDITORS

 

To the Board of Directors and Shareholders of

 

WAYCARE TECHNOLOGIES LTD.

 

We have audited the accompanying consolidated financial statements of Waycare Technologies Ltd and its subsidiary, which comprise the consolidated balance sheets as of December 31, 2020 and the related consolidated statements of comprehensive loss , convertible preferred shares and shareholders' deficiency and cash flows for the year then ended, and the related notes to the consolidated financial statements.

 

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in conformity with U.S. generally accepted accounting principles; this includes the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free of material misstatement, whether due to fraud or error.

 

Auditor’s Responsibility

Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.

 

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion.

 

An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

 

Opinion

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Waycare Technologies Ltd and its subsidiary at December 31, 2020 and the consolidated results of their comprehensive loss and its their cash flows for the year then ended in conformity with U.S. generally accepted accounting principles.

 

KOST FORER GABBAY & KASIERER

 

A Member of Ernst & Young Global

 

Tel-Aviv, Israel

September 14, 2021

 

 

 
- 2 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

CONSOLIDATED BALANCE SHEET

U.S. dollars in thousands (except share data)

 

 

 

 

 

December 31,

 

 

 

Note

 

 

2020

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

$ 1,299

 

Restricted cash

 

 

 

 

 

82

 

Trade receivables

 

 

 

 

 

642

 

Other current assets

 

 

3

 

 

 

108

 

 

 

 

 

 

 

 

 

 

Total current assets

 

 

 

 

 

 

2,131

 

 

 

 

 

 

 

 

 

 

NON - CURRENT ASSETS:

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

4

 

 

 

48

 

 

 

 

 

 

 

 

 

 

Total assets

 

 

 

 

 

$ 2,179

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS DEFICIENCY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

Trade payables

 

 

 

 

 

$ 74

 

Employees and payroll accruals

 

 

 

 

 

 

300

 

Other accounts payables

 

 

 

 

 

 

217

 

Deferred revenues

 

 

 

 

 

 

93

 

 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

 

 

 

 

684

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

 

 

 

 

$ 684

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Convertible preferred shares, NIS 0.01 par value per share, 2,552,902 shares authorized: 2,388,279 issued and outstanding as of December 31, 2020

 

 

6

 

 

$ 9,625

 

 

 

 

 

 

 

 

 

 

SHAREHOLDERS' DEFICIENCY:

 

 

7

 

 

 

 

 

Ordinary shares, NIS 0.01 par value per share, 7,471,028 shares authorized: 943,545 issued and outstanding as of December 31, 2020

 

 

 

 

 

 

3

 

Additional paid in capital

 

 

 

 

 

 

791

 

Accumulated deficit

 

 

 

 

 

 

(8,924 )

Treasury shares

 

 

 

 

 

(*)

 

 

 

 

 

 

 

 

 

 

Total shareholders' deficiency

 

 

 

 

 

 

(8,130 )

 

 

 

 

 

 

 

 

 

Total liabilities, convertible preferred shares and shareholders' deficiency

 

 

 

 

 

$ 2,179

 

 

(*) Represents less than $ 1 thousand.

 

The accompanying notes are an integral part of the financial statements.

 

 
- 3 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS

U.S. dollars in thousands (except share data)

    

 

 

 

 

December 31, Year ended

 

 

 

Note

 

 

2020

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

$ 2,034

 

Cost of revenues

 

 

 

 

 

709

 

 

 

 

 

 

 

 

 

Gross profit

 

 

 

 

 

1,325

 

 

 

 

 

 

 

 

 

Research and development expenses

 

 

 

 

 

2,842

 

Marketing, general and administrative expenses

 

 

 

 

 

2,158

 

 

 

 

 

 

 

 

 

Total operating expenses

 

 

 

 

 

5,000

 

 

 

 

 

 

 

 

 

Operating loss

 

 

 

 

 

3,676

 

 

 

 

 

 

 

 

 

Financial expenses, net

 

 

 

 

 

28

 

 

 

 

 

 

 

 

 

Loss before taxes on income

 

 

 

 

 

3,703

 

 

 

 

 

 

 

 

 

Taxes on income

 

 

8

 

 

 

22

 

 

 

 

 

 

 

 

 

 

Total comprehensive loss

 

 

 

 

 

$ 3,725

 

 

The accompanying notes are an integral part of the financial statements.

 

 
- 4 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

  

CONSOLIDATED STATEMENT OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' DEFICIENCY

U.S. dollars in thousands (except share data)

   

 

 

Convertible Preferred Shares

 

 

Amount

 

 

Ordinary Shares

 

 

Amount

 

 

Treasury Shares

 

 

Additional paid in capital

 

 

Accumulated

deficit

 

 

Total Shareholders' deficiency

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 1, 2020

 

 

2,388,279

 

 

$ 9,625

 

 

 

1,051,300

 

 

$ 3

 

 

$

(*)

 

 

$ 388

 

 

$ (5,199 )

 

$ (4,808 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

402

 

 

 

-

 

 

 

402

 

Exercise of options

 

 

-

 

 

 

-

 

 

 

33,912

 

 

 

-

 

 

 

-

 

 

 

1

 

 

 

-

 

 

 

1

 

Purchase of treasury shares

 

 

-

 

 

 

-

 

 

 

(141,667 )

 

(*)

 

 

(*)

 

 

 

-

 

 

 

-

 

 

(*)

 

Loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,725 )

 

 

(3,725 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2020

 

 

2,388,279

 

 

$ 9,625

 

 

 

943,545

 

 

$ 3

 

 

$ (*)

 

 

$ 791

 

 

$ (8,924 )

 

$ (8,130 )

 

(*) Represents less than $ 1 thousand.

 

The accompanying notes are an integral part of the financial statements.

 

 
- 5 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands (except share data)

   

 

 

December 31, Year ended

 

 

 

2020

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Loss

 

$ (3,725 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

Depreciation on fixed assets

 

 

17

 

Stock-based compensation

 

 

402

 

Increase in trade receivables

 

 

(416 )

Decrease in other accounts receivable

 

 

162

 

Increase in trade payables

 

 

15

 

Increase in employees and payroll accruals

 

 

83

 

Increase in other accounts payable

 

 

195

 

Increase in deferred revenues

 

 

93

 

 

 

 

 

 

Net cash used in operating activities

 

 

(3,174 )

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Purchase of property and equipment

 

 

(34 )

 

 

 

 

 

Net cash used in investing activities

 

 

(34 )

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Proceeds from short-term deposit

 

 

24

 

Exercise of options

 

 

1

 

 

 

 

 

 

Net cash provided by financing activities

 

 

25

 

 

 

 

 

 

Decrease in cash, cash equivalents and restricted cash

 

 

(3,183 )

Cash, cash equivalents and restricted cash at the beginning of the period

 

 

4,564

 

 

 

 

 

 

Cash, cash equivalents and restricted cash at the end of the period

 

$ 1,381

 

 

 

 

 

 

Supplemental disclosures of cash flow information:

 

 

 

 

Income tax payments

 

$ 18

 

 

(*) Represents less than $ 1 thousand.

 

The accompanying notes are an integral part of the financial statements.

 

 
- 6 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

 

NOTE 1:- GENERAL

 

 

a.

Waycare Technologies Ltd. ("the Company") was incorporated as a private company on June 27, 2016 under the laws of the state of Israel and began its operations on July 1, 2017.

 

 

 

 

 

The Company develops systems in the smart transportation field, which identify car accidents, and traffic jams.

   

 

b.

In April 2018, the Company has established a fully owned subsidiary in the United States, Waycare Technologies INC ("Waycare INC"). Waycare INC engages in sales and marketing services for the Company.

 

 

 

 

c.

Since inception, the Company has incurred accumulated deficit of $8,924 and negative cash flows from operating activities. The Company is dependent upon additional funding sources in order to continue its activities and therefore there is uncertainty about the ability to generate positive cash flows from its activities in the future. The Purchaser is committed to financially support the Company in order to enable it to fulfil its financial obligation for a period of at least 12 months from the date the approval of the financial statements (see note 9).

 

 

 

 

d.

In December 2019, a novel coronavirus (“COVID-19”) was reported in China. During March 2020, it was declared a pandemic by the World Health Organization (“WHO"). According to health authorities in different locations, the Company instructed its employees to work from home. The Company has also suspended all non-essential travel worldwide for its employees. It is not possible at this time to estimate the impact that COVID-19 could have on the Company business, as the impact will depend on future developments, which are highly uncertain and cannot be predicted.

  

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES

 

 

a.

Basis of presentation and principles of consolidation:

 

 

 

 

 

These consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) as set forth in the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC). The consolidated financial statements include accounts of the Company’s wholly owned subsidiary. All intercompany accounts and transactions are eliminated.

 

 

 

 

b.

Use of estimates:

 

 

 

 

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company’s management believes that the estimates, judgment and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

  

 
- 7 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

 

c.

Functional currency, presentation currency and foreign currency:

 

 

 

 

 

The functional currency of the Company and its subsidiaries is the U.S. dollar. Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are re-measured into U.S. dollars in accordance with Accounting Standard Codification (“ASC”) No. 830 “Foreign Currency Matters.” All transaction gains and losses of the re-measured monetary balance sheet items are reflected in the consolidated statements of operations as financial income or expenses, as appropriate.

 

 

d.

Cash equivalents:

 

 

 

 

 

The Company considers highly liquid investments, including unrestricted short-term bank deposits with an original maturity of three months or less from the date of investment, to be cash equivalents.

 

 

 

 

e.

Restricted Cash:

 

 

 

 

 

As collateral for guarantees provided to secure credit cards payments and rental agreement, the Company pledged deposits in favor of a bank.

 

 

 

 

f.

Fair value of financial instruments:

 

 

 

 

 

The accounting guidance for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:

   

 

·

Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

 

 

 

 

·

Level 2 Inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

 

 

 

 

·

Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.

 

 

 

 

Cash equivalents, restricted cash , trade receivable, trade payable, employee and payroll accruals and accrued expenses are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date.

   

 
- 8 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

 

g.

Concentration of credit risks:

 

 

 

 

 

Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, restricted cash, and accounts receivable.

  

Cash, cash equivalents and restricted cash are deposited in major banks in Israel and the US. Such investments in Israel and the US may be in excess of insured limits and are not insured in other jurisdictions. Generally, cash and cash equivalents may be redeemed upon demand and, therefore, bear minimal risk. The Company grants credit to its customers in the normal course of business.

 

 

 

 

h.

Property and equipment, net:

 

 

 

 

 

Property and equipment are measured at cost less accumulated depreciation. Depreciation is calculated on a straight-line basis at annual rates which are considered adequate for the depreciation of the assets over their estimated useful life as follows:

   

 

 

%

Computers and software

 

33

Office and furniture

 

15

Leasehold improvements

 

*

  

 

*)

Leasehold improvements are amortized according to the straight-line method over the lease term or in accordance with the estimated life of the improvement, whichever is shorter.

 

 

 

 

i.

Impairment of long-lived assets:

 

 

 

 

 

The long-lived assets of the Company are reviewed for impairment in accordance with ASC No. 360, “Property, Plant and Equipment” (“ASC No. 360”), whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2020, no impairment losses have been identified.

  

 
- 9 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

 

j.

Severance pay:

 

 

 

 

 

The Company agreements with most of the employees are in accordance with section 14 of the Severance Pay Law - 1963 which provide that the Company's contributions to severance pay fund shall cover its entire severance obligation. Accumulated amounts in the pension funds and with the insurance companies are not under the control or administration of the Company, and accordingly, neither those amounts nor the corresponding accrual for severance pay are reflected in the balance sheet. The obligation of the Company, under law and labor agreements, for termination benefits to employees not covered by the aforementioned pension or insurance plans, are included in the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.

 

Severance expense for the years ended December 31, 2020 amounted to $90.

 

 

 

 

k.

Revenue recognition:

 

 

 

 

 

The Company adopted ASC 606 on January 1, 2019, using the modified retrospective transition method applied to those contracts which were not completed as of January 1, 2019. The new standard application had no material effect on the pattern of revenue recognition.

  

The Company derives its revenues mainly from subscription fees for the usage of its platform and related services.

   

The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

  

The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the company expects to receive in exchange for those services.

  

The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods or services to the customer, excluding taxes assessed by a governmental authority, that are collected by the Company from a customer.

  

The Company services provided on a subscription basis and recognized ratably over the contract period.

  

The Company applied the practical expedient in Topic 606 and did not evaluate contracts of one year or less for the existence of a significant financing component.

   

The Company recognizes contract liabilities (deferred revenues) when it receives advance payments from customers before performance obligations have been performed.

   

 
- 10 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

 

l.

Cost of sales:

 

 

 

 

 

Cost of products is comprised of employee's salaries, servers cost and related costs.

 

 

 

 

m.

Research and development expenses:

 

 

 

 

 

Research and development expenses are charged to expenses, as incurred.

 

 

 

 

n.

Accounting for stock-based compensation:

 

 

 

 

 

ASC 718 - "Compensation-stock Compensation"- ("ASC 718") requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award is recognized as an expense over the requisite service periods in the Company's statements operations. The Company recognizes forfeitures of awards as they occur.

 

The Company recognizes compensation expense for the value of its awards on a straight-line basis over the requisite service period of each of the awards.

 

The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing model. The option-pricing model requires a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Since the Company is not traded, the expected volatility is derived from the average historical share volatilities of several unrelated public companies within the Company’s industry that the Company considers to be comparable to its own business . The expected term represents the period that options are expected to be outstanding. For option grants that are considered to be “plain vanilla,” the Company determines the expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the contractual life of the options. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.

 

The fair value for options granted in 2020 is estimated at the date of grant using a Black-Scholes options pricing model with the following assumptions:

  

 

 

December 31, Year ended

 

 

 

2020

 

 

 

 

 

Expected term (in years)

 

 

6.25

 

Expected volatility

 

 

80 %

Risk-free interest rate

 

0.20%-0.27

%

Dividend yield

 

 

0 %

 

 
- 11 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

  

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

 

o.

Income taxes:

 

 

 

 

 

The Company accounts for income taxes in accordance with ASC 740, “Income Taxes” (“ASC 740”). This standard prescribes the use of the liability method, whereby deferred tax asset and liability accounts balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.

 

The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value, and if it is more likely than not that some portion of the entire deferred tax asset will not be realized.

 

The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740-10, “Income Taxes”. Accounting guidance addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements, under which a Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.

 

The tax benefits recognized in the consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement.

 

 

 

 

p.

Recently issued accounting pronouncements:

 

 

 

 

 

In February 2016, the FASB issued ASU 2016-02, "Leases". The updated standard aims to increase transparency and comparability among organizations by requiring lessees to recognize lease assets and lease liabilities on the balance sheet and requiring disclosure of key information about leasing arrangements. As currently issued and amended, the standard will become effective for the Company in 2022. Early adoption is permitted. The Company is currently evaluating the impact of adoption on its consolidated financial statement.

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the timelier recognition of losses. The new accounting standard will be effective for the fiscal year beginning on January 1, 2023, including interim periods within that year. The Company is currently evaluating the impact of adopting this new guidance on its financial statements.

  

 
- 12 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

  

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

 

NOTE 3:- OTHER CURRENT ASSETS

 

 

 

December 31,

 

 

 

2020

 

 

 

 

 

Government authorities

 

$ 43

 

Prepaid Expanses

 

 

65

 

 

 

 

 

 

 

 

$ 108

 

 

NOTE 4:- PROPERTY AND EQUIPMENT, NET

 

 

 

December 31,

 

 

 

2020

 

Cost:

 

 

 

Office and Furniture

 

$ 5

 

Leasehold Improvement

 

 

3

 

Computers and software

 

 

68

 

 

 

 

 

 

 

 

$ 76

 

 

 

 

 

 

Accumulated depreciation

 

$ (28 )

 

 

 

 

 

Depreciated cost

 

$ 48

 

 

 

Depreciation expenses amounted to $ 17 for the years ended December 31, 2020.

  

NOTE 5:- COMMITMENTS AND CONTINGENT LIABILITIES

 

 

The Company leases facilities under an operating lease that expires on September 9, 2022. The lease agreement entered into by the Company includes an extension option for an additional 2 years.

    

Aggregate minimum lease and rental payments under non-cancelable operating leases as of December 31, 2020, are (in the aggregate) and for each succeeding fiscal year below:

 

Year ended December 31,

 

Operating

leases payments

 

 

 

 

 

2021

 

$ 95

 

2022

 

 

71

 

 

 

 

 

 

Total

 

$ 166

 

  

 

Total operating leases expenses for the years ended December 31, 2020 amounted to $89.

 

 
- 13 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

  

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

   

NOTE 6:- CONVERTIBLE PREFERRED SHARES

 

 

a.

The Composition of the Company's Convertible Preferred shares is as follows:

    

 

 

December 31, 2020

 

 

 

Authorized

 

 

Issued and

outstanding

 

Preferred shares A of NIS 0.01 par value each

 

 

1,628,181

 

 

 

1,475,538

 

Preferred shares A1 of NIS 0.01 par value each

 

 

250,982

 

 

 

239,002

 

Preferred shares A2 of NIS 0.01 par value each

 

 

152,378

 

 

 

152,378

 

Preferred shares A3 of NIS 0.01 par value each

 

 

359,052

 

 

 

359,052

 

Preferred shares A4 of NIS 0.01 par value each

 

 

162,309

 

 

 

162,309

 

 

 

 

 

 

 

 

 

 

Total

 

 

2,552,902

 

 

 

2,388,279

 

 

 

b.

Preferred shares rights:

 

 

 

 

 

Dividend rights- Dividends shall be distributed to the Shareholders (other than holders of Deferred Shares on account of such Shares) out of any assets of the Company legally available thereof when, as and if declared by the Board, subject to the Special Majority Requirements. Except in the case of a Distribution Event, any Dividends shall be paid to all holders of Preferred Shares and Ordinary Shares in proportion to the number of Ordinary Shares that would be held by each such holder if all Preferred Shares were converted into Ordinary Shares as of the record date for such Dividend.

 

Liquidation rights- In the event of: (i) any dissolution, liquidation, bankruptcy, or reorganization or winding-up of the Company; or (ii) a Deemed Liquidation ,then all assets or proceeds legally available for distribution to the Shareholders the Company in connection with such Distribution Event shall be distributed among the Shareholders according to the following order of preference:

  

(a). First, the Preferred Shareholders will be entitled to receive, (pro rata among themselves), prior to any distribution to any other Shareholders, an amount per Preferred Share equal to the greater of the following: (i) the applicable Original Issue Price of such Preferred Share, as may be adjusted to reflect stock split, stock combination, stock dividend, recapitalization or like events, plus cumulative interest thereon at the rate of eight percent (8%) per annum, non-compounded, from the date on which the applicable Original Issue Price of such Preferred Share has been received by the Company and until the date of the distribution, plus an amount equal to all declared but unpaid dividends on each such Preferred Share, less (A) the amount of distributions actually received in any prior Distribution Event, and (B) any Dividends actually received on such Preferred Share on account of any preference of such Preferred Share; or such amount per share that would actually be distributed to the holder of each such Preferred Share, assuming the conversion of such share into Ordinary Shares immediately prior to distribution of the Distributable Proceeds, and a distribution to all holders of Ordinary Shares and any such Preferred Shares so assumed converted, on a pro rata, pari passu basis, plus an amount equal to all declared but unpaid dividends on each such Preferred Share.

  

 
- 14 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

  

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

  

NOTE 6:- CONVERTIBLE PREFERRED SHARES (Cont.)

 

 

If upon the occurrence of such Distribution Event, the Distributable Proceeds shall be insufficient to permit the full payment of the Preferred Preference Amount, then the Distributable Proceeds shall be distributed ratably among all the holders of Preferred Shares only, and in proportion to the preferential amounts such Shareholders are entitled to receive as specified above. (b). Second, after the holders of the Preferred Shares have received the full Preferred Preference Amount, the remaining Distributable Proceeds shall be distributed only among the holders of Ordinary Shares on a pro rata basis, excluding for such purposes Ordinary Shares which both (i) are the result of the conversion of Preferred Shares, and (ii) have already received payments on account of the Preferred Preference Amount in the framework of such Distribution Event.

 

Voting rights - each holder of Preferred Shares is entitled to one vote per each share held by it (on an as-converted-to-ordinary share basis).

 

Conversion - each Preferred Share is automatically convertible into ordinary shares, at the respective holder's option, or automatically upon a qualified IPO of the Company or upon written demand of the Investor Majority (each as defined in the AoA) for each respective class of shares. The initial conversion ratio for each Preferred Share is 1:1. The conversion price per Preferred Share will be adjusted in the event of recapitalizations, share splits, ordinary share dividends, subdivisions and combinations of ordinary shares, as well in the event of certain anti-dilution events.

 

Redemption - The convertible preferred shares do not contain any date-certain redemption features. The convertible preferred shares are redeemable upon certain deemed liquidation events.

 

Classification of convertible preferred shares - The deemed liquidation preference provisions of the convertible preferred shares are considered contingent redemption provisions that are not solely within the Company’s control. Accordingly, the convertible preferred shares have been presented outside of permanent equity in the temporary equity (mezzanine) section of the consolidated balance sheets.

 

NOTE 7:- SHAREHOLDERS' EQUITY

 

 

a.

Composition:

 

 

 

December 31, 2020

 

 

 

Authorized

 

 

Issued and outstanding

 

 

 

Number of shares

 

 

 

 

 

 

 

 

Ordinary shares of NIS 0.01 par value each

 

 

7,471,028

 

 

 

943,545

 

 

 
- 15 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

  

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

   

NOTE 7:- SHAREHOLDERS' EQUITY (Cont.)

 

 

b.

Shares rights:

   

 

1.

Ordinary shares confer upon their holders the right to receive notices of general meetings of the Company, to participate and vote in the general meetings, to appoint and dismiss directors, to participate in the distribution of dividends and to participate in distribution of surplus assets and funds of the Company in the event of liquidation (after the preference of Preferred shares) and certain other rights, all as are specified in the Company's Articles of Association.

  

 

c.

Treasury shares:

 

 

 

 

 

In November 2020, the Company purchased 141,667 Ordinary shares from one of the shareholders in price of 0.01 NIS per share.

   

 

d.

Share option plan:

 

 

 

 

 

The Company has authorized through its 2018 Share Option Plan (the "Plan”), an available pool of Ordinary shares of the Company from which to grant options to officers, advisors, management and other key employees of up to 539,417 ordinary shares. The options granted generally have a four-year vesting period and expire ten years after the date of grant, subject to the terms set forth in the Plan. Options granted under the Plan that are cancelled or forfeited before expiration become available for future grant. As of December 31, 2020, 206,510 of the Company's options are available for future grants.

 

The following table presents the changes in the number of share options and the weighted average exercise prices of share options:

 

 

 

Number of options

 

 

Weighted average exercise price

 

 

Weighted
average
remaining
contractual term
(in years)

 

 

Aggregate
Intrinsic
value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of January 1, 2020

 

 

327,139

 

 

$ 0.45

 

 

 

9.74

 

 

$ 314,524

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

92,008

 

 

 

0.29

 

 

 

 

 

 

 

 

 

Exercised

 

 

(33,912 )

 

 

0.03

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(56,223 )

 

 

0.77

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2020

 

 

329,012

 

 

$ 0.39

 

 

 

8.24

 

 

$ 256,208

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable as of December 31, 2020

 

 

219,267

 

 

$ 0.34

 

 

 

 

 

 

 

 

 

 

 

The weighted-average grant date fair value of options granted during the year ended December 31, 2020 was $1.34.

   

 
- 16 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

  

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

 

NOTE 7:- SHAREHOLDERS' EQUITY (Cont.)

 

 

As of December 31, 2020, there was $213 of total unrecognized compensation cost related to non-vested options that are expected to be recognized over a weighted average period of approximately 2.69 years.

   

The share-based compensation expense by line item in the accompanying consolidated statements of operations is summarized as follows:

  

 

 

December 31,

 

 

 

2020

 

 

 

 

 

Cost of revenues

 

$ 4

 

Research and development

 

 

198

 

Marketing, general and administrative

 

 

200

 

 

 

 

 

 

Total

 

$ 402

 

  

 

Total share-based compensation expenses resulting from share options granted to non-employees included in the statement of operations for the year ended December 31, 2020 were immaterial.

   

NOTE 8:- TAXES ON INCOME

 

 

a.

Tax rates in Israel:

 

 

 

 

 

The Israeli corporate income tax rate was 23% in 2020.

 

A company is taxable on its real capital gains at the corporate income tax rate in the year of sale.

  

 

b.

Income taxes on non-Israeli subsidiary:

 

 

 

 

 

Non-Israeli subsidiary is taxed according to the laws in its respective country of residence.

 

 

 

 

c.

Net operating losses carry forwards:

 

 

 

 

 

The Company has accumulated losses for tax purposes as of December 31, 2020 in the amount of approximately $6,000 which may be carried forward and offset against taxable income in the future for an indefinite period.

 

 

 

 

d.

Tax assessment:

 

 

 

 

 

The Company has not received assessments since its inception.

 

 

 

 

e.

Deferred taxes:

 

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company's deferred tax assets are comprised of operating loss carryforwards and other temporary differences.

  

 
- 17 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

  

NOTE 8:- TAXES ON INCOME (Cont.)

 

 

Significant components of the Company's deferred tax assets are as follows:

  

 

 

December 31,

 

 

 

2020

 

 

 

 

 

Loss carryforward

 

$ 1,508

 

Research and development expenses

 

 

445

 

Accruals and reserves

 

 

11

 

 

 

 

 

 

Deferred tax assets before valuation allowance

 

 

1,964

 

Less - valuation allowance

 

 

(1,964 )

 

 

 

 

 

Net deferred tax assets

 

$ -

 

 

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets depends on the generation of future taxable income during the periods in which those temporary differences and tax loss carryforward are deductible. Management considers the projected taxable income and tax-planning strategies in making this assessment. In consideration of the Company’s accumulated losses and the uncertainty of its ability to utilize its deferred tax assets in the future, management currently believes that it is more likely than not that the Company will not realize its deferred tax assets and accordingly recorded a valuation allowance to fully offset all the deferred tax assets.

   

 

f.

Reconciliation of the theoretical tax expense (benefit) to the actual tax expense:

 

 

 

 

 

In 2020, the main reconciling item of the statutory tax rate of the Company to the effective tax rate is tax loss carryforwards and other deferred tax assets for which a full valuation allowance was provided.

 

Loss before taxes on income consists of the following:

  

 

 

December 31,

 

 

 

2020

 

 

 

 

 

Domestic (Israel)

 

$ 3,778

 

Foreign

 

 

(76 )

 

 

 

 

 

Total

 

$

3,703

 

 

 
- 18 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

  

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

    

NOTE 9:- SUBSEQUENT EVENTS

 

 

1.

In April 2021 the Company entered into a loan agreement with the bank in total amount of $1,500. During the six months period ended June 30, 2021, the Company repaid $100, the remainder was paid subsequent to June 30, 2021 by the Company and Rekor, System Inc as part of the completion of the acquisition (see Note 9(2)).

 

 

 

 

2.

On August 6, 2021, the Company signed an agreement of a Shares Purchase Agreement ("SPA") to be fully acquired by Rekor Systems Inc. (the "Buyer"), for an aggregate purchase price of $61,000, subject to the terms of the agreement. The SPA contains customary representations, warranties, and covenants of the Company and the Buyer.

  

 

- 19 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD.

AND ITS SUBSIDIARY

 

INTERIM CONSOLIDATED FINANCIAL STATEMENTS

 

AS OF JUNE 30, 2021

 

U.S. DOLLARS IN THOUSANDS

 

UNAUDITED

 

INDEX

 

 

Page

 

 

Consolidated Balance Sheets

2 – 3

 

 

Consolidated Statements of Comprehensive loss

4

 

 

Consolidated Statements of Convertible Preferred Shares and Shareholders' Deficiency

5

 

 

Consolidated Statements of Cash Flows

6

 

 

Notes to Interim Consolidated Financial Statements

7 - 10

 

 
- 1 -

Table of Contents

 

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

  

CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands  

 

 

 

 

 

 

June 30,

 

 

December 31

 

 

 

Note

 

 

2021

 

 

2020

 

 

 

 

 

 

Unaudited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

$ 903

 

 

$ 1,299

 

Restricted cash

 

 

 

 

 

 

88

 

 

 

82

 

Short-term deposits

 

 

 

 

 

 

14

 

 

 

-

 

Trade receivables

 

 

 

 

 

1,280

 

 

 

642

 

Other current assets

 

 

 

 

 

 

131

 

 

 

108

 

 

 

 

 

 

 

 

 

 

 

 

 

Total current assets

 

 

 

 

 

 

2,416

 

 

 

2,131

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NON - CURRENT ASSETS:

 

 

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

 

 

 

 

70

 

 

 

48

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

 

 

 

 

$ 2,486

 

 

$ 2,179

 

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 

 
- 2 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands (except share and per share data)

   

 

 

 

 

June 30,

 

 

December 31

 

 

 

Note

 

 

2021

 

 

2020

 

 

 

 

 

Unaudited

 

 

 

LIABILITIES AND SHAREHOLDERS' DEFICIENCY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

 

Trade payables

 

 

 

 

$ 134

 

 

$ 74

 

Employees and payroll accruals

 

 

 

 

 

340

 

 

 

300

 

Other accounts payables

 

 

 

 

 

322

 

 

 

217

 

Current maturities of long-term loan

 

7

 

 

 

600

 

 

 

-

 

Deferred revenues

 

 

 

 

 

49

 

 

 

93

 

 

 

 

 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$ 1,445

 

 

$ 684

 

 

 

 

 

 

 

 

 

 

 

 

 

NON - CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

 

 

 

Long-term loan

 

 

7

 

 

 

800

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

 

 

 

 

$ 2,245

 

 

$ 684

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Convertible preferred shares

 

 

5

 

 

$ 9,625

 

 

$ 9,625

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SHAREHOLDERS' DEFICIENCY:

 

 

6

 

 

 

 

 

 

 

 

 

Ordinary shares

 

 

 

 

 

 

3

 

 

 

3

 

Additional paid in capital

 

 

 

 

 

 

1,008

 

 

 

791

 

Accumulated deficit

 

 

 

 

 

 

(10,395 )

 

 

(8,924 )

Treasury shares

 

 

 

 

 

(*)

 

 

(*)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total shareholders' deficiency

 

 

 

 

 

 

(9,384 )

 

 

(8,130 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities, convertible preferred shares and shareholders' deficiency

 

 

 

 

 

$ 2,486

 

 

$ 2,179

 

 

(*) Represents less than $ 1 thousand.

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 

 
- 3 -

Table of Contents

  

WAYCARE TECHNOLOGIES LTD. AND ITS SUBSIDIARY

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS

U.S. dollars in thousands (except share and per share data)

   

 

 

Six months ended

 

 

 

June 30, 2021

 

 

 

Unaudited

 

 

 

 

 

Revenues

 

$ 1,727

 

Cost of revenues

 

 

622

 

 

 

 

 

 

Gross profit

 

 

1,105

 

 

 

 

 

 

Research and development expenses

 

 

1,434

 

Marketing, general, and administrative expenses

 

 

1,125

 

 

 

 

 

 

Total operating expenses

 

 

2,559

 

 

 

 

 

 

Operating loss

 

 

1,454

 

 

 

 

 

 

Financial expenses, net

 

 

16

 

 

 

 

 

 

Loss before taxes on income

 

 

1,470

 

 

 

 

 

 

Taxes on income

 

 

1

 

 

 

 

 

 

Total comprehensive loss

 

$ 1,471

 

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 

 
- 4 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD.

 

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' DEFICIENCY

U.S. dollars in thousands (except share and per share data)

   

 

 

Convertible Preferred Shares

 

 

Amount

 

 

Ordinary Shares

 

 

Amount

 

 

Treasury Shares

 

 

Additional paid in capital

 

 

Accumulated

deficit

 

 

Total Shareholders' deficiency

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 1, 2021

 

 

2,388,279

 

 

$ 9,625

 

 

 

943,545

 

 

$ 3

 

 

$

(*)

 

 

$ 791

 

 

$ (8,924 )

 

$ (8,130 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

217

 

 

 

-

 

 

 

217

 

Loss for the period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,471 )

 

 

(1,471 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of June 30, 2021

 

 

2,388,279

 

 

$ 9,625

 

 

 

943,545

 

 

$ 3

 

 

$

 (*)

 

 

$ 1,008

 

 

$ (10,395 )

 

$ (9,384 )

 

(*) Represents less than $ 1.

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 

 
- 5 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

U.S. dollars in thousands

   

 

 

Six months ended

 

 

 

2021

 

 

 

Unaudited

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net loss

 

$ (1,471 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

Depreciation

 

 

13

 

Share-based compensation

 

 

217

 

Increase in trade receivables

 

 

(638 )

Increase in other current assets

 

 

(23 )

Increase in trade payables

 

 

60

 

Increase in employees and payroll accruals

 

 

40

 

Increase in other current liabilities

 

 

105

 

Decrease in deferred revenues

 

 

(44 )

 

 

 

 

 

Net cash used in operating activities

 

$ (1,741 )

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Purchase of property and equipment

 

 

(35 )

Short-term deposit

 

 

(14 )

 

 

 

 

 

Net cash used in investing activities

 

$ (49 )

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Receipt of long-term loan

 

 

1,500

 

Repayment of long-term loan

 

 

(100 )

 

 

 

 

 

Net cash provided by financing activities

 

 

 

 

 

 

$ 1,400

 

 

 

 

 

 

Decrease in cash, cash equivalents and restricted cash

 

 

(390 )

Cash, cash equivalents and restricted cash at beginning of period

 

 

1,381

 

 

 

 

 

 

Cash, cash equivalents and restricted cash at end of period

 

$ 991

 

 

 

 

 

 

Supplemental disclosures of cash flow information:

 

 

 

 

 

 

 

 

 

Interest paid

 

$ 8

 

 

The accompanying notes are an integral part of the interim consolidated financial statements.

 

 
- 6 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD.

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 1:- GENERAL

 

 

a.

Waycare Technologies Ltd. ("the Company") was incorporated as a private company on June 27, 2016 under the laws of the state of Israel and began its operations on July 1, 2017. The Company develops systems in the smart transportation field, which identify car accidents, and traffic jams.

 

 

 

 

b.

In April 2018, the Company has established a fully owned subsidiary in the United States, Waycare Technologies INC ("Waycare INC"). Waycare INC engages in sales and marketing services for the Company.

 

 

 

 

c.

Since inception, the Company has incurred accumulated deficit of $10,395 and negative cash flows from operating activities. The Company is dependent upon additional funding sources in order to continue its activities and therefore there is uncertainty about the ability to generate positive cash flows from its activities in the future. The Purchaser is committed to financially support the Company in order to enable it to fulfil its financial obligation for a period of at least 12 months from the date the approval of the financial statements (see note 8).

 

 

 

 

d.

The novel coronavirus ("COVID-19") pandemic has created, and may continue to create significant uncertainty in macroeconomic conditions, and the extent of its impact on the Company's operational and financial performance will depend on certain developments, including the duration and spread of the outbreak and the impact on the Company's customers. The Company considered the impact of COVID-19 on the estimates and assumptions and determined that there were no material adverse impacts on the interim consolidated financial statements for the period ended June 30, 2021. As events continue to evolve and additional information becomes available, the Company's estimates and assumptions may change materially in future periods.

 

 

 

 

 

As of June 30, 2021, the Company had cash, cash equivalents and restricted cash of $991K.

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

 

 

These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes for the year ended December 31, 2020. The significant accounting policies applied in the annual financial statements of the Company as of December 31, 2020, are applied consistently in these interim consolidated financial statements.

  

 
- 7 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD.

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 3:- UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

 

 

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.

 

Operating results for the six-month period ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ended December 31, 2021.

  

NOTE 4:- COMMITMENTS AND CONTINGENT LIABILITIES

  

 

The Company leases facilities under an operating lease that expires on September 9, 2022. The lease agreement entered by the Company includes an extension option for an additional 2 years.

  

Aggregate minimum lease and rental payments under non-cancelable operating leases as of June 30, 2021, are (in the aggregate) and for each succeeding fiscal year below:

  

June 30, 2021 (unaudited)

 

Operating

leases payments

 

 

 

 

 

2021

 

$ 47

 

2022

 

 

71

 

 

 

 

 

 

Total

 

$ 118

 

 

 

Total operating leases expenses for the six-month period ended June 30, 2021 amounted to $48.

  

NOTE 5:- CONVERTIBLE PREFERRED SHARES

  

 

The Composition of the Company's Convertible Preferred shares is as follows:

   

 

 

June 30, 2021 (unaudited)

 

 

 

Authorized

 

 

Issued and outstanding

 

Preferred shares A of NIS 0.01 par value each

 

 

1,628,181

 

 

 

1,475,538

 

Preferred shares A1 of NIS 0.01 par value each

 

 

250,982

 

 

 

239,002

 

Preferred shares A2 of NIS 0.01 par value each

 

 

152,378

 

 

 

152,378

 

Preferred shares A3 of NIS 0.01 par value each

 

 

359,052

 

 

 

359,052

 

Preferred shares A4 of NIS 0.01 par value each

 

 

162,309

 

 

 

162,309

 

 

 

 

 

 

 

 

 

 

Total

 

 

2,552,902

 

 

 

2,388,279

 

 

 
- 8 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD.

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 6:- SHAREHOLDERS' DEFICIENCY

 

 

a.

Ordinary share capital is composed as follows:

 

 

 

June 30, 2021 (unaudited)

 

 

 

Authorized

 

 

Issued and outstanding

 

 

 

Number of shares

 

 

 

 

 

 

 

 

Ordinary shares of NIS 0.01 par value each

 

 

7,471,028

 

 

 

943,545

 

 

 

b.

Stock Option

 

 

 

 

 

A summary of the status of options under the Plan as of June 30, 2021 and changes during the relevant period ended on that date is presented below:

  

 

 

Six months ended June 30, 2021 (unaudited)

 

 

 

Number

of options

 

 

Weighted

average

exercise

price

 

 

Weighted
average
remaining
contractual term
(in years)

 

 

Aggregate
Intrinsic
value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of January 1, 2021

 

 

329,012

 

 

$ 0.39

 

 

 

8.24

 

 

$ 256,208

 

Granted

 

 

170,145

 

 

$ 0.77

 

 

 

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(32,172 )

 

$ 0.44

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of June 30, 2021

 

 

466,985

 

 

$ 0.52

 

 

 

8.26

 

 

$ 549,624

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable as of June 30, 2021

 

 

282,082

 

 

$ 0.78

 

 

 

 

 

 

 

 

 

 

 

As of June 30, 2021, there were unrecognized compensation costs of $290, which are expected to be recognized over a weighted average period of approximately 2.84 years. The weighted-average grant date fair value of options granted during the six months period ended June 30, 2021 was $1.46.

  

 
- 9 -

Table of Contents

 

WAYCARE TECHNOLOGIES LTD.

 

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

 

NOTE 7:- LONG TERM LOAN

 

 

In April 2021, a new long-term loan agreement in an amount of $1,500 was signed between the Company and Silicon Valley Bank (the "Bank"). In accordance with the agreement, the principal amount will be repaid in 30 equal monthly installments, started on May 31, 2021. The Loan bears an interest at annum rate of the greater of (i) the Prime Rate plus 2.5% or (ii) 5.75%, which interest shall be payable monthly in accordance with the agreement. During the six months period ended June 30, 2021, the Company repaid $100, the remainder was paid subsequent to June 30, 2021 by the Company and Rekor, System Inc as part of the completion of the acquisition (see Note 8).

  

NOTE 8:- SUBSEQUENT EVENTS

 

 

On August 6, 2021, the Company signed an agreement of a Shares Purchase Agreement ("SPA") to be fully acquired by Rekor Systems Inc. (the "Buyer"), for an aggregate purchase price of $61,000, subject to the terms of the agreement. The SPA contains customary representations, warranties, and covenants of the Company and the Buyer.

  

 
- 10 -

 

EXHIBIT 99.2

 

Unaudited Pro Forma Condensed Combined Financial Information

 

On August 18, 2021, Rekor Systems, Inc. (the “Company”) entered into that certain share purchase agreement (the “Purchase Agreement”) by and among the Company, Waycare Technologies Ltd. (“Waycare”), the sellers of Waycare named in the Purchase Agreement (the “Sellers”), and Shareholder Representative Services LLC, solely in its capacity as the representative of the Sellers, pursuant to which the Company acquired 100% of the issued and outstanding capital stock of Waycare from the Sellers (the “Acquisition”).

 

The following unaudited pro forma condensed combined financial information presents the historical consolidated balance sheet and statements of operations of the Company and the historical balance sheet and statements of operations of Waycare, adjusted to reflect the Acquisition as of June 30, 2021 and January 1, 2020, respectively. The historical financial statements of the Company and Waycare were prepared in accordance with accounting principals generally accepted in the United States of America ("U.S. GAAP"). The unaudited pro forma condensed combined financial information is presented in accordance with the rules specified by Article 11 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”) and has been prepared using the assumptions described in the notes thereto. The following unaudited pro forma condensed combined balance sheet and statements of operations are provided for informational purposes only. The unaudited pro forma condensed combined statements of operations are not necessarily indicative of the Company’s historical or future results of operations or financial condition had the Acquisition been completed on the date indicated. In addition, the unaudited pro forma condensed combined balance sheet and statements of operations do not purport to project the future financial position or operating results of the combined company. The unaudited pro forma condensed combined balance sheet as of June 30, 2021 is presented as if the Acquisition had occurred on June 30, 2021. The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2021 and for the year ended December 31, 2020 are presented as if the Acquisition had occurred on January 1, 2020.

 

The unaudited pro forma condensed combined financial information should be read in conjunction with the Company’s historical consolidated financial statements and their accompanying notes presented in its Annual Report on Form 10-K for the year ended December 31, 2020 and its Quarterly Report on Form 10-Q for the six months ended June 30, 2021, as well as the audited consolidated financial statements of Waycare for the year ended December 31, 2020 and the unaudited interim financial statements as of and for the six months ended June 30, 2021 included as Exhibit 99.1 to this Amendment No. 2 of the Current Report on Form 8-K.

 

 
1

 

 

Rekor Systems, Inc. and Subsidiaries

Unaudited Pro Forma Condensed Combined Balance Sheet

(Dollars in thousands, except share amounts)

 

 

 

Historical

 

 

 

 

 

 

 

 

 

 

 

Rekor Systems, Inc.

 

 

Waycare  Technologies, Ltd.

 

 

Pro Forma

 

 

 

 

Pro Forma Condensed Combined with Waycare

 

 

 

June 30, 2021

 

 

Adjustments

 

 

Notes

 

June 30, 2021

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$ 69,032

 

 

$ 903

 

 

$ (40,813 )

 

 (A)

 

$ 29,122

 

Restricted cash and cash equivalents

 

 

856

 

 

 

88

 

 

 

-

 

 

 

 

 

944

 

Short-term investments

 

 

12,998

 

 

 

-

 

 

 

-

 

 

 

 

 

12,998

 

Accounts receivable, net

 

 

1,996

 

 

 

1,280

 

 

 

-

 

 

 

 

 

3,276

 

Inventory

 

 

1,357

 

 

 

-

 

 

 

-

 

 

 

 

 

1,357

 

Note receivable, current portion

 

 

340

 

 

 

-

 

 

 

-

 

 

 

 

 

340

 

Other current assets, net

 

 

1,267

 

 

 

145

 

 

 

-

 

 

 

 

 

1,412

 

Total current assets

 

 

87,846

 

 

 

2,416

 

 

 

(40,813 )

 

 

 

 

49,449

 

Long-term assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

Property and equipment, net

 

 

1,564

 

 

 

70

 

 

 

-

 

 

 

 

 

1,634

 

Right-of-use lease assets, net

 

 

277

 

 

 

-

 

 

 

96

 

 

 (B)

 

 

373

 

Goodwill

 

 

6,336

 

 

 

-

 

 

 

13,676

 

 

 (D)

 

 

20,012

 

Intangible assets, net

 

 

6,224

 

 

 

-

 

 

 

59,459

 

 

 (D)

 

 

65,683

 

Note receivable, long-term

 

 

1,190

 

 

 

-

 

 

 

-

 

 

 

 

 

1,190

 

SAFE investment

 

 

1,000

 

 

 

-

 

 

 

-

 

 

 

 

 

1,000

 

Other long-term assets

 

 

127

 

 

 

-

 

 

 

-

 

 

 

 

 

127

 

Total long-term assets

 

 

16,718

 

 

 

70

 

 

 

73,231

 

 

 

 

 

90,019

 

Total assets

 

$ 104,564

 

 

$ 2,486

 

 

$ 32,418

 

 

 

 

$ 139,468

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$ 4,130

 

 

$ 796

 

 

$ 1,249

 

 

 (J)

 

$ 6,175

 

Notes payable, current portion

 

 

990

 

 

 

-

 

 

 

-

 

 

 

 

 

990

 

Loan payable, current portion

 

 

911

 

 

 

600

 

 

 

(600 )

 

 (E)

 

 

911

 

Lease liability, short-term

 

 

142

 

 

 

-

 

 

 

82

 

 

 (B)

 

 

224

 

Contract liabilities

 

 

1,782

 

 

 

49

 

 

 

-

 

 

 

 

 

1,831

 

Current liabilities of discontinued operations

 

 

129

 

 

 

-

 

 

 

-

 

 

 

 

 

129

 

Total current liabilities

 

 

8,084

 

 

 

1,445

 

 

 

731

 

 

 

 

 

10,260

 

Long-term Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loan payable, long-term

 

 

55

 

 

 

800

 

 

 

(800 )

 

 (E)

 

 

55

 

Lease liability, long-term

 

 

144

 

 

 

-

 

 

 

14

 

 

 (B)

 

 

158

 

Contract liabilities, long-term

 

 

1,077

 

 

 

-

 

 

 

-

 

 

 

 

 

1,077

 

Deferred tax liability, long-term

 

 

31

 

 

 

-

 

 

 

13,676

 

 

 (C)

 

 

13,707

 

Other long-term liabilities

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

Total long-term liabilities

 

 

1,307

 

 

 

800

 

 

 

12,890

 

 

 

 

 

14,997

 

Total liabilities

 

 

9,391

 

 

 

2,245

 

 

 

13,621

 

 

 

 

 

25,257

 

Convertible preferred shares

 

 

-

 

 

 

9,625

 

 

 

(9,625 )

 

 (H)

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock, $0.0001 par value; authorized; 100,000,000 shares

 

 

4

 

 

 

3

 

 

 

(3 )

 

 (H)

 

 

4

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 (F)

 

 

-

 

Treasury stock

 

 

(319 )

 

 

-

 

 

 

-

 

 

 

 

 

(319 )

Additional paid-in capital

 

 

148,754

 

 

 

1,008

 

 

 

(1,008 )

 

 (H)

 

 

148,754

 

 

 

 

-

 

 

 

-

 

 

 

20,287

 

 

 (F)

 

 

20,287

 

Accumulated other comprehensive income

 

 

3

 

 

 

-

 

 

 

-

 

 

 

 

 

3

 

Accumulated deficit

 

 

(53,269 )

 

 

(10,395 )

 

 

10,395

 

 

 (H)

 

 

(53,269 )

 

 

 

-

 

 

 

-

 

 

 

(1,249 )

 

 (J)

 

 

(1,249 )

Total stockholders’ equity

 

 

95,173

 

 

 

(9,384 )

 

 

28,422

 

 

 

 

 

114,211

 

Total liabilities and stockholders’ equity

 

$ 104,564

 

 

$ 2,486

 

 

$ 32,418

 

 

 

 

$ 139,468

 

 

The accompanying notes are an integral part of these unaudited pro forma condensed combined financial statements.

 

 
2

 

  

Rekor Systems, Inc. and Subsidiaries

Unaudited Pro Forma Condensed Combined Statement of Operations

For the Year Ended December 31, 2020

(Dollars in thousands, except share amounts)

 

 

 

Historical

 

 

 

 

 

 

 

 

 

 

Rekor Systems, Inc.

 

 

Waycare  Technologies, Ltd.

 

 

 

 

 

 

Pro Forma Condensed Combined with Waycare

 

 

 

Year ended

December 31, 2020

 

 

Pro Forma

Adjustments

 

 

Notes

 

Year ended

December 31, 2020

 

Revenue

 

$ 9,234

 

 

$ 2,034

 

 

$ -

 

 

 

 

$ 11,268

 

Cost of revenue

 

 

3,533

 

 

 

709

 

 

 

8,494

 

 

 (D)

 

 

12,736

 

Gross profit

 

 

5,701

 

 

 

1,325

 

 

 

(8,494 )

 

 

 

 

(1,468 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

 

12,117

 

 

 

1,216

 

 

 

1,405

 

 

 (I)

 

 

14,738

 

Selling and marketing expenses

 

 

2,247

 

 

 

942

 

 

 

-

 

 

 

 

 

3,189

 

Research and development expenses

 

 

3,185

 

 

 

2,842

 

 

 

-

 

 

 

 

 

6,027

 

Operating expenses

 

 

17,549

 

 

 

5,000

 

 

 

1,405

 

 

 

 

 

23,954

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(11,848 )

 

 

(3,675 )

 

 

(9,899 )

 

 

 

 

(25,422 )

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on extinguishment of debt

 

 

(3,281 )

 

 

-

 

 

 

-

 

 

 

 

 

(3,281 )

Interest expense

 

 

(2,503 )

 

 

-

 

 

 

-

 

 

 

 

 

(2,503 )

Other income (expense)

 

 

62

 

 

 

(28 )

 

 

-

 

 

 

 

 

34

 

Gain on sale of business

 

 

3,631

 

 

 

-

 

 

 

-

 

 

 

 

 

3,631

 

Total other expense

 

 

(2,091 )

 

 

(28 )

 

 

-

 

 

 

 

 

(2,119 )

Loss before income taxes

 

 

(13,939 )

 

 

(3,703 )

 

 

(9,899 )

 

 

 

 

(27,541 )

Income tax provision

 

 

(23 )

 

 

(22 )

 

 

-

 

 

 

 

 

(45 )

Equity in loss of investee

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

Net loss from continuing operations

 

 

(13,962 )

 

 

(3,725 )

 

 

(9,899 )

 

 

 

 

(27,586 )

Net loss from discontinued operations

 

 

(220 )

 

 

-

 

 

 

-

 

 

 

 

 

(220 )

Net loss

 

 

(14,182 )

 

 

(3,725 )

 

 

(9,899 )

 

 

 

 

(27,806 )

Comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss from continuing operations

 

 

(13,962 )

 

 

(3,725 )

 

 

(9,899 )

 

 

 

 

(27,586 )

Change in unrealized gain on short-term investments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

Total comprehensive loss from continuing operations

 

 

(13,962 )

 

 

(3,725 )

 

 

(9,899 )

 

 

 

 

(27,586 )

Total comprehensive loss

 

$ (14,182 )

 

$ (3,725 )

 

$ (9,899 )

 

 

 

$ (27,806 )

Loss per common share from continuing operations - basic and diluted

 

 

(0.63 )

 

 

 

 

 

 

 

 

 

 

 

 

(1.07 )

Loss per common share discontinued operations - basic and diluted

 

 

(0.01 )

 

 

 

 

 

 

 

 

 

 

 

 

(0.01 )

Loss per common share - basic and diluted

 

$ (0.64 )

 

 

 

 

 

 

 

 

 

 

 

$ (1.08 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

24,192,680

 

 

 

 

 

 

 

2,784,474

 

 

 (F)

 

 

26,977,154

 

    

 The accompanying notes are an integral part of these unaudited pro forma condensed combined financial statements.

 

 
3

 

   

Rekor Systems, Inc. and Subsidiaries

Unaudited Pro Forma Condensed Combined Statement of Operations

For the Six Months ended June 30, 2021

(Dollars in thousands, except share amounts)

 

 

 

Historical

 

 

 

 

 

 

 

 

 

 

 

Rekor Systems, Inc.

 

 

Waycare  Technologies, Ltd.

 

 

 

 

 

 

 

Pro Forma Condensed Combined with Waycare

 

 

 

Six Months ended

June 30, 2021

 

 

Pro Forma

Adjustments

 

 

 

Notes

 

Six Months ended

June 30, 2021

 

Revenue

 

$ 8,491

 

 

$ 1,727

 

 

$ -

 

 

 

 

$ 10,218

 

Cost of revenue

 

 

3,394

 

 

 

622

 

 

 

4,247

 

 

(D)

 

 

8,263

 

Gross profit

 

 

5,097

 

 

 

1,105

 

 

 

(4,247 )

 

 

 

 

1,955

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

 

10,427

 

 

 

687

 

 

 

702

 

 

(I)

 

 

11,816

 

Selling and marketing expenses

 

 

1,920

 

 

 

438

 

 

 

-

 

 

 

 

 

2,358

 

Research and development expenses

 

 

2,741

 

 

 

1,434

 

 

 

-

 

 

 

 

 

4,175

 

Operating expenses

 

 

15,088

 

 

 

2,559

 

 

 

702

 

 

 

 

 

18,349

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(9,991 )

 

 

(1,454 )

 

 

(4,949 )

 

 

 

 

(16,394 )

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(50 )

 

 

(8 )

 

 

8

 

 

(K)

 

 

(50 )

Other income (expense)

 

 

34

 

 

 

(8 )

 

 

-

 

 

 

 

 

26

 

Total other income (expense)

 

 

(16 )

 

 

(16 )

 

 

8

 

 

 

 

 

(24 )

Loss before income taxes

 

 

(10,007 )

 

 

(1,470 )

 

 

(4,941 )

 

 

 

 

(16,418 )

Income tax provision

 

 

(7 )

 

 

(1 )

 

 

-

 

 

 

 

 

(8 )

Equity in loss of investee

 

 

(150 )

 

 

-

 

 

 

-

 

 

 

 

 

(150 )

Net loss from continuing operations

 

 

(10,164 )

 

 

(1,471 )

 

 

(4,941 )

 

 

 

 

(16,576 )

Net loss from discontinued operations

 

 

(4 )

 

 

-

 

 

 

-

 

 

 

 

 

(4 )

Net loss

 

 

(10,168 )

 

 

(1,471 )

 

 

(4,941 )

 

 

 

 

(16,580 )

Comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss from continuing operations

 

 

(10,164 )

 

 

-

 

 

 

(4,941 )

 

 

 

 

(16,576 )

Change in unrealized gain on short-term investments

 

 

4

 

 

 

-

 

 

 

-

 

 

 

 

 

4

 

Total comprehensive loss from continuing operations

 

 

(10,160 )

 

 

(1,471 )

 

 

(4,941 )

 

 

 

 

(16,572 )

Total comprehensive loss

 

$ (10,164 )

 

$ (1,471 )

 

$ (4,941 )

 

 

 

$ (16,576 )

Loss per common share from continuing operations - basic and diluted

 

 

(0.27 )

 

 

 

 

 

 

 

 

 

 

 

 

(0.41 )

Loss per common share discontinued operations - basic and diluted

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

Loss per common share - basic and diluted

 

$ (0.27 )

 

 

 

 

 

 

 

 

 

 

 

$ (0.41 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

37,657,471

 

 

 

 

 

 

 

2,784,474

 

 

(F)

 

 

40,441,945

 

 

 

 

-

 

 

 

 

 

 

 

228,749

 

 

(G)

 

 

228,749

 

    

The accompanying notes are an integral part of these unaudited pro forma condensed combined financial statements.

 

 
4

 

 

Rekor Systems, Inc. and Subsidiaries

Notes to Unaudited Pro Forma Condensed Combined Financial Statements

 

NOTE 1 – BASIS OF PRESENTATION

 

The unaudited pro forma condensed combined financial statements were prepared in accordance with U.S. GAAP and pursuant to the rules and regulations of SEC Regulation S-X and present the pro forma financial position and results of operations of the combined companies based upon the historical data of the Company and Waycare, after giving effect to the Acquisition and pro forma adjustments as described in these notes. The Acquisition was accounted for as a business combination in accordance with the guidance contained in the Financial Accounting Standards Board’s Accounting Standards Codification ASC Topic 805, Business Combinations (“ASC 805”).

 

The unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X as amended by the final rule, Release No. 33-10786 “Amendments to Financial Disclosures about Acquired and Disposed Businesses.” The transaction accounting adjustments consist of those necessary to account for the transaction. The unaudited pro forma condensed combined balance sheet as of June 30, 2021 is presented as if the Acquisition had occurred on June 30, 2021. The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2021 and for the year ended December 31, 2020 are presented as if the Acquisition had occurred on January 1, 2020.

   

The unaudited pro forma combined financial information also reflects reclassification adjustments to certain financial statement captions included in Waycare’s historical consolidated financial statements to align with the corresponding financial statement captions included in the Company’s historical presentation. The reclassifications had no impact on the historical results of operations, net loss, total assets, total liabilities, or total stockholders' equity reported by the Company or Waycare. This information has been prepared in accordance with Article 11 of Regulation S-X, and is for informational purposes only and is subject to a number of uncertainties and assumptions as described in the accompanying notes.

 

The historical consolidated financial statements of the Company and Waycare are prepared in accordance with U.S. GAAP and are shown in U.S. dollars. Dollar amounts, except per share data, in the notes to the unaudited condensed combined financial statements are rounded to the closest $1,000.

 

The unaudited pro forma condensed combined financial statements are presented for illustrative purposes only and are not necessarily indicative of the financial position or operating results that would have been achieved had the Acquisition been completed as of the dates indicated above.

 

NOTE 2 – PRELIMINARY PURCHASE PRICE ALLOCATION

 

The table below summarizes the allocation of the purchase price to the tangible and intangible assets acquired and liabilities assumed based on management’s preliminary estimates of their respective fair values for purposes of the pro forma financial information as of the acquisition date, August 18, 2021 (dollars in thousands):

 

 
5

 

 

Cash paid

 

$ 40,813

 

Common stock issued

 

 

20,287

 

Total Consideration

 

 

61,100

 

Assets

 

 

 

 

Cash and cash equivalents

 

 

44

 

Restricted cash and cash equivalents

 

 

89

 

Accounts receivable

 

 

389

 

Other current assets

 

 

267

 

Property and equipment

 

 

72

 

Intangible assets

 

 

60,674

 

Total assets acquired

 

 

61,535

 

Liabilities

 

 

 

 

Accounts payable and accrued expenses

 

 

399

 

Contract liabilities

 

 

36

 

Deferred tax liability, long-term

 

 

13,955

 

Total liabilities assumed

 

 

14,390

 

Fair value of identifiable net assets acquired

 

 

47,145

 

Goodwill

 

$ 13,955

 

    

This preliminary purchase price allocation has been used to prepare pro forma adjustments in the unaudited pro forma condensed combined balance sheet and statement of operations. Due to the recent completion of the acquisition, the determination of the purchase price and the allocation of the purchase price used in the unaudited pro forma condensed combined financial information are based upon preliminary estimates, which are subject to change during the measurement period (up to one year from the acquisition date) as the Company finalizes the valuations of the assets acquired and liabilities assumed, including, but not limited accounts receivable, other current assets, property and equipment, intangible assets, accounts payable, and contract liabilities. The final allocation could differ materially from the preliminary allocation used in the pro forma adjustments.

 

NOTE 3 – PRO FORMA ADJUSTMENTS


The pro forma adjustments included in the unaudited pro forma condensed combined financial statements are as follows:

 

 

(A)

Cash and cash equivalents and Restricted cash and cash equivalents – Adjustment reflects $40,813,000 of cash paid as part of the closing of Waycare and the execution of the Purchase Agreement.

 

 

 

 

(B)

Adoption of ASC 842 - Adjustment to reflect the implementation of ASC 842, Leases, by Waycare to conform to the adoption date as a public business entity and the Company’s accounting policies.

 

 

 

 

(C)

Deferred tax liability, long-term - Adjustment reflects the addition of $13,676,000 of deferred tax liabilities resulting from purchase accounting adjustments, in particular, the step up in financial reporting basis of the intangible assets acquired. The Company's estimate for deferred taxes is preliminary and could be subject to material change based on the Company's further analysis of certain tax attributes acquired and as the Company finalizes other aspects of the allocation of the purchase price for this acquisition. This deferred tax liability was determined by multiplying the temporary differences between financial reporting and tax bases of the acquired assets by 23 percent, the 2021 corporate tax rate in Israel.

 

 

 

 

(D)

Goodwill and Intangible Assets - Adjustment reflects the preliminary estimated fair value of intangible assets of $59,459,000 and goodwill of $13,676,000 recognized upon the acquisition of Waycare.

 

 

 

 

 

As part of the preliminary valuation analysis, the Company identified intangible assets related to software intellectual property. The fair value of identifiable intangible assets is estimated primarily using the “income approach”, which requires a forecast of the expected future cash flows. Since the detailed valuation analysis of Waycare’s identifiable intangible assets has not been completed, the preliminary estimates of fair value will likely differ from final amounts the Company will calculate after completing a detailed valuation analysis.

 

The fair values assigned to tangible and identifiable intangible assets acquired and liabilities assumed are based on management’s estimates and assumptions.

   

 
6

 

 

The following table presents the preliminary fair value of the identified intangible assets acquired at the date of acquisition and its estimated useful life (dollars in thousands):

 

 

 

 

 

 

 

 

Amortization Expense

 

 

 

Preliminary Value

 

 

Useful Life

 

Six Months ended

June 30, 2021

 

 

Year ended

December 31, 2020

 

Developed technology

 

$ 59,459

 

 

 7 years

 

$ 4,247

 

 

$ 8,494

 

Total preliminary intangible assets subject to amortization

 

$ 59,459

 

 

 

 

$ 4,247

 

 

$ 8,494

 

 

The adjustment for amortization expense of the developed software is reflected as part of cost of revenue for the respective periods.

  

 

(E)

Loan Payable Long-term and Other Long-term Liabilities – In accordance with the Purchase Agreement, all of Waycare's outstanding loans payable were settled as of the closing date. This adjustment is meant to reflect the settlement of these liabilities.

 

 

 

 

(F)

Common Stock and Additional Paid in Capital – Adjustment reflects issuance of 2,784,474 shares of Rekor common stock valued at $20,287,000, as part of the consideration received as a result of the Purchase Agreement.

 

 

 

 

(G)

Common Stock – Adjustment reflects issuance of 228,749 shares of Rekor common stock as a result of the vesting the of RSU's issued.

 

 

 

 

(H)

Elimination of Waycare Equity – Adjustments reflect an elimination of the Waycare’s historical equity balances, including common stock.

 

 

 

 

(I)

General and Administrative Expense – Adjustment represents the net increase of certain executive compensation and benefits in connection with the employment agreement for the Waycare executive to become an officer of the Company, resulting in an increase in annual compensation concurrent with the acquisition. Additionally, the adjustment reflects the net increase in share-based compensation expenses as a result of the $5,000,000 RSU’s that were issued to Waycare employees and the retirement of Waycare’s stock options. A break of out the adjustment is as follows (dollars in thousands):

 

 

 

Six Months ended

June 30, 2021

 

 

Year ended

December 31, 2020

 

 

 

 

 

 

 

 

Net increase in compensation expense

 

$ 70

 

 

$ 140

 

Net increase in share-based compensation expense

 

 

632

 

 

 

1,265

 

Total

 

$ 702

 

 

$ 1,405

 

   

 

(J)

Transaction Costs - Adjustment reflects the transaction costs incurred, or are expected to be incurred by Rekor or Waycare subsequent to June 30, 2021, which have not yet been included in the historical financial statements.

 

 

 

 

(K)

Interest Expense - Adjustment to eliminate Waycare’s interest expense as it was related to debt that was not transferred to the Company.

 

 

7